This study will evaluate the effectiveness and benefit of treatment with onabotulinumtoxinA
in Chronic Migraine patients who have received a minimum of 7 treatment cycles.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01749410
Ages eligible for Study
18 Years to 65 Years
Genders eligible for Study
Accepts Healthy Volunteers
15 or more headache days over a 30 day period
A minimum of 7 treatment cycles with onabotulinumtoxinA
Any treatment cycle dose of onabotulinumtoxinA greater than 200 units
All locations for NCT01749410
United States (1)
Encinitas, California, United States
Trial results for NCT01749410
Participant Flow: Overall Study
33 / 33
Completed / Started
Serious Adverse Events
0 / 33
Affected / At Risk
Other Adverse Events
4 / 33
Affected / At Risk
View full eligibility
Tris trial is registered with FDA with number: NCT01749410. The sponsor of the trial is Allergan and it is looking for 33 volunteers for the current phase.
Official trial title:
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.